中国医药公司亿腾医药（Eddingpharm）以及美国制药企业礼来公司（Eli Lilly）近日宣布，双方已签署协议，由亿腾医药以3.75亿美元收购礼来公司在中国市场销售的两款著名抗生素产品希刻劳®（Ceclor®）和稳可信®（Vancocin®），一并收购的还有位于中国苏州的希刻劳生产厂。亿腾医药法务副总裁陈苗洁和法务总监潘文卿在此交易中带领多方律师团队为项目提供法律保障。
Eddingpharm, a China-based specialty pharmaceutical company, and Eli Lilly, a U.S. pharmaceutical company, recently announced that they had entered into an agreement pursuant to which Eddingpharm would acquire Eli Lilly’s rights in China for two well-known antibiotics products, Ceclor® and Vancocin®, as well as its Ceclor manufacturing facility in Suzhou, China, for a total purchase price of US$375 million. Ms. Miaojie Chen, Vice President, Legal Department, and Mr. Miles Pan, Legal Director, of Eddingpharm led a team of several law firms in providing legal advice to Eddingpharm in connection with this transaction.
国际律所徳汇律师事务所（Dorsey & Whitney）代表亿腾医药作为其在本交易中的主要法律顾问，为亿腾提供全面的并购法律服务。德汇团队由其纽约公司业务部主管合伙人潘惜唇（Catherine X. Pan-Giordano）牵头领导，主要成员还包括德汇公司业务部合伙人David Mack以及科技业务部主管合伙人Michael McCormick。方达（Fangda）为亿腾医药提供中国法服务，还与凯易（Kirkland & Ellis）一起为其融资提供法律服务。礼来公司在本项目上的主要法律顾问为瑞格（Ropes & Gray）。
International law firm Dorsey and Whitney represents Eddingpharm in this transaction as its lead outside counsel. The Dorsey team is led by Catherine X. Pan-Giordano, the Corporate Group Head of the firm’s New York offices, and includes David Mack, a partner in the firm’s Corporate Group, and Michael McCormick, Co-Chair of the firm’s Technology Commerce Practice Group. Eddingpharm has also engaged Fangda Partners as its PRC counsel, and Fangda Partners and Kirkland & Ellis as its financing counsel. Ropes & Gray acts as Eli Lilly’s lead outside counsel in this transaction.
德汇律师事务所始创于1912年，全球拥有19家分所，数十年来一直致力于发展中国业务，为中国众多的知名民营企业、大型国有企业和金融机构提供跨境投资交易和商业争端解决领域的国际法律服务。德汇的全美及中国联合业务部不仅包括上海、北京和香港分所，而且汇聚了纽约、伦敦、硅谷、盐湖城、洛杉矶、西雅图、明尼亚波利斯、丹佛、华盛顿、达拉斯、特拉华、多伦多、温哥华等全球其他分所和代表不同执业领域的精英律师，以无缝连接的方式为中国客户提供一体化的全球法律服务。
Dorsey & Whitney was founded in 1912 and has 19 offices around the world. The firm has long been committed to developing its China practice, and has advised Chinese clients in a great variety of cross-border transactions and commercial dispute resolution matters, including well-known private companies, large state-owned enterprises and financial institutions. Consisting of both experienced lawyers in our China offices in Shanghai, Beijing and Hong Kong, and other attorneys from various practice areas who are based in New York, London, Silicon Valley, Salt Lake City, Southern California, Seattle, Minneapolis, Denver, Washington D.C., Dallas, Delaware, Toronto and Vancouver, Dorsey & Whitney’s US-China Practice Group provides integrated international legal services to Chinese clients in a seamless manner.
如需了解关于本交易的更多信息，请点击此处阅读本交易的新闻稿。
For more information, please refer to the press release about the transaction.